This inventor holds 2 USPTO granted patents. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1983-1985.
Company Filing History:
Years Active: 1983-1985
Title: Tibor Zilahi: Innovator in Antimicrobial Compositions
Introduction
Tibor Zilahi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of antimicrobial compositions, holding a total of 2 patents. His work focuses on developing synergistic antimicrobial agents that can be utilized in both pharmaceutical and veterinary applications.
Latest Patents
Zilahi's latest patents include innovative formulations that combine various antimicrobial components. One of his key inventions is a synergistic antimicrobial composition that contains primycin, doxycycline, and sisomicin. This invention aims to enhance the effectiveness of these compounds when used together. The composition comprises 5 to 50 percent by weight of a primycin component derived from the fermentation product of Thermonospora galeriensis, along with 95 to 50 percent by weight of at least one other component selected from doxycycline and sisomicin compounds. The doxycycline compounds include doxycycline itself, its salts with mineral acids, and doxycycline trihydrate. The sisomicin compounds consist of sisomicin and its derivatives, which have various substitutions.
Career Highlights
Tibor Zilahi is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a company known for its pharmaceutical products. His work at this organization has allowed him to focus on the development of innovative antimicrobial solutions that address critical health challenges.
Collaborations
Zilahi has collaborated with notable colleagues in his field, including Gabor Kulcsar and Gyula Sebestyen. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Tibor Zilahi's contributions to antimicrobial compositions highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing pharmaceutical science through collaboration and research.